Wall Street Analyst Forum 2006 Presenter Profiles
NEW YORK--Feb. 23, 2006--The Wall Street Analyst Forum 2006 takes place Feb. 27-Mar. 02, 2006 at the Princeton Club in New York City. For in-depth information about the event, visit http://www.analyst-conference.com.Below are profiles from Wall Street Analyst Forum 2006 presenters. Breaking news releases and advisories are available at http://www.tradeshownews.com, Business Wire's trade show, conference, and event news resource.
Business Wire is the official news wire service for Wall Street Analyst Forum 2006.
Company: Accentia Biopharmaceuticals
Ticker Symbol & Exchange: NASDAQ: ABPI
Investor Relations Contact: Adam S. Holdsworth, 212-825-3210
Web: www.accentia.net
Date of Presentation: Monday, February 27th
Accentia Biopharmaceuticals, Inc. is a biopharmaceutical company
focused on the development and commercialization of late-stage
clinical products in the therapeutic areas of respiratory disease and
oncology. The Company's SinuNase(TM) product is a novel application
and formulation of a known anti-fungal to treat chronic sinusitis
(rhinosinusitis) licensed from the Mayo Foundation for Medical
Education and Research, and BiovaxID(TM) is a patient-specific
anti-cancer vaccine focusing on the treatment of follicular
non-Hodgkins' lymphoma. BiovaxID which is being developed by our
subsidiary Biovest International, Inc. (OTCBB:BVTI - News) is
currently in Phase 3 clinical trial. In addition, Accentia has a
growing specialty pharmaceutical business, TEAMM Pharmaceuticals, with
a portfolio of currently marketed products plus a pipeline of
additional products under development by third parties. For further
information, please visit our web site: http://www.accentia.net.
Company: Aerosonic Corporation
Ticker Symbol & Exchange: AMEX: AIM
Investor Relations Contact: Pam Lagano, Lagano & Associates, Inc.,
727.726.7910
Web: www.aerosonic.com
Date of Presentation: March 2, 2006
For over 50 years, Aerosonic Corporation has provided precision
flight products for commercial, business and military aircraft,
including the Joint Strike Fighter, BlackHawk helicopters and the
Cessna Mustang. From digital cockpit instrumentation to the latest in
avionics technology, Aerosonic plays a vital role in aviation safety.
The Company offers its customers a global network for products and
support in North America, Europe and the Far East. Florida based
Aerosonic was recently named to Forbes list of 200 Best Small
Companies.
Company: Agilysys, Inc.
Ticker Symbol & Exchange:
Investor Relations Contact: Martin F. Ellis or Steve Baisden;
(Ellis: 440.720-8682) or (Baisden:
440.720.8603)
Web: www.agilysys.com
Date of Presentation: Monday, February 27, 2006
Agilysys is one of the foremost distributors and premier resellers
of enterprise computer technology solutions. It has a proven track
record of delivering complex server and storage hardware, software and
services to resellers, large and medium-sized corporate customers, as
well as public-sector clients across a diverse set of industries. In
addition, the company provides customer-centric software applications
and services focused on the retail and hospitality markets.
Headquartered in Mayfield Heights, Ohio, Agilysys has sales offices
throughout the United States and Canada.
Company: Altair Nanotechnologies Inc.
Ticker Symbol & Exchange: NASDAQ:ALTI
Investor Relations Contact: Marty Tullio, McCloud Communications.com;
949.553.9748
Web: Altairnano.com
Date of Presentation: Monday, February 27, 2006
Altairnano, a leading supplier and innovator of advancedceramic
nanomaterial technology, owns a 100,000 square-foot facility comprised
of offices, laboratories and semi-works capable of manufacturing a
variety of nanomaterials. The company, which has focused on
applications where its nanotechnology may enable new high growth
markets, has applied its proprietary nanotechnology to develop new
materials in four key areas - high power battery systems,
pharma/biotech, performance materials and pigment production. Within
the healthcare sector, the company is pursuing market applications in
pharmaceuticals, coating materials for implants, dental materials and
drug delivery - products that will enhance the lifestyle of humans and
animals alike.
Company: Biophan Technologies, Inc.
Ticker Symbol & Exchange: OTC: BB: BIPH FWB: BTN
Investor Relations Contact: Carolyn Hotchkiss, 585-214-2441
Web: www.biophan.com
Date of Presentation: 2/28/06
Biophan develops and markets technologies to make medical devices
safe and compatible with magnetic resonance imaging. The Company also
recently announced a relationship to help develop and commercialize
the MYO-VAD(TM) - a novel, MRI compatible ventricular assist device
with potential for significantly improving the treatment of heart
disease. Biophan and its licensors now hold a total of 157 U.S.
patents, licenses, or applications including 48 issued U.S. patents.
Biophan has joint development and licensing agreements with Boston
Scientific Corporation and NASA's Ames Center for Nanotechnology. For
more information, please visit www.biophan.com. (Stock Exchanges: OTC:
BIPH and FWB: BTN)
Company: BioSphere Medical, Inc.
Ticker Symbol & Exchange: BSMD:NASDAQ
Investor Relations Contact: Maura Gedid, 212 836-9605
Web: www.biospheremed.com
Date of Presentation: 2/28/06
BioSphere Medical applies its proprietary, bioengineered
microsphere technology to a variety of medical therapies through the
use of embolotherapy. Embolotherapy works by reducing blood flow to
targeted areas of the body. The Company is the world leader in the
growing Uterine Fibroid Embolization market, and is also active in the
treatment of liver cancer using embolization.
Company: Boston Life Sciences, Inc.
Ticker Symbol & Exchange: BLSI: NASDAQ SmallCap
Investor Relations Contact: Meredith Patin, 508-497-2360 ext. 239
Web: www.bostonlifesciences.com
Date of Presentation: February 27, 2006
Boston Life Sciences, Inc. is engaged in the research and clinical
development of diagnostic and therapeutic products for central nervous
system(CNS) disorders. ALTROPANE(R) molecular imaging agent is in
Phase III clinical trials for the diagnosis of Parkinsonian
Syndrome(PS) and a Phase II clinical trial for the diagnosis of
Attention Deficit Hyperactivity Disorder(ADHD). Research and
pre-clinical CNS programs include Inosine for the treatment of stroke,
O-1369 for the treatment of Parkinson's disease and FLUORATEC(TM), a
second generation molecular imaging agent, for PS and ADHD. BLSI's
current research collaborations include Harvard Medical School,
Children's Hospital of Boston and University of
Massachusetts-Worcester.
Company: BPI ENERGY
Ticker Symbol & Exchange: Amex: BPG
Investor Relations Contact: Matthew Dennis, CFA; 440-353-0552
Web: www.bpi-energy.com ir@bpi-energy.com
Date of Presentation: Tuesday, February 28, 2006
BPI Energy is engaged in the exploration, production and
commercial sale of coalbed methane in the Illinois Basin. The company
controls the dominant coalbed methane acreage position in the
Basin--418,435 acres. BPI has 10.3 billion cubic feet of estimated
proved reserves based on 94 well locations. With only two percent of
its total acreage position under development, the potential to
significantly increase shareholder value via proving up larger
proportions of its mineral rights portfolio is considerable. BPI has
world-class corporate partners in BHP Billiton, Halliburton, and
Schlumberger; major interstate pipelines traversing its property; and
ready access to gas-consuming markets.
Company: CH Energy Group, Inc.
Ticker Symbol & Exchange: CHG, NYSE
Investor Relations Contact: Stacey A. Renner, 845-486-5730
Web: www.CHEnergyGroup.com
Date of Presentation: March 1, 2006
CH Energy Group, Inc., headquartered in Poughkeepsie, New York, is
the holding company of Central Hudson Gas & Electric Corporation and
Central Hudson Enterprises Corporation. Central Hudson Gas & Electric
Corporation is a regulated transmission and distribution utility
serving approximately 363,500 electric and natural gas customers in
New York State's Mid-Hudson River Valley. Central Hudson Enterprises
Corporation is a non-regulated subsidiary focused on fuel distribution
to more than 80,000 customers, through its Griffith Energy Services
subsidiary, and several renewable energy investments, including fuel
ethanol production and wind energy.
Company: Cord Blood America, Inc.
Ticker Symbol & Exchange: CBAI (OTCBB)
Investor Relations Contact: Trevor Bryant, 888-882-8673
Web: www.cordpartners.com
Date of Presentation: 2/28/2006
Cord Blood America, Inc., through its wholly owned subsidiary,
Cord Partners, Inc., markets a service to preserve the umbilical cord
blood for future use exclusively by the donating family. The
collection takes less than five minutes, is painless, easy and
non-invasive. Cryogenically preserved umbilical cord stem cells have
already been used to treat 75 major diseases, including leukemia,
severe anemia, metabolic blood disorders and immune deficiencies. This
list is guaranteed to grow as medical research learns more about the
incredible healing power of stem cells. Revenues for CBAI for the nine
months ended September 30, 2005, increased 96 percent to approximately
$1.9 million compared to revenues of approximately $968,000 for the
same period in 2004.
Company: EnerSys
Ticker Symbol & Exchange: ENS (NYSE)
Investor Relations Contact: Michael G. Hastings, (610) 208-1761
Web: http://www.enersys.com
Date of Presentation: March 2, 2006
EnerSys is the world's largest manufacturer of industrial
lead-acid batteries with a worldwide market share of approximately 27%
and sales in excess of $1.2 billion. Industrial batteries are used
primarily to power electric forklift trucks and to provide battery
backup power for the continuous operation of critical
telecommunications and uninterruptible power systems during power
disruptions. EnerSys has 20 plants in North America, Europe and Asia
to service local and global customers. The company is in solid growth
markets and sales have increased a total of 26% over the last two
fiscal years, and an additional 16% the first nine months of the
current fiscal year.
Company: INTERMAGNETICS
Ticker Symbol & Exchange: IMGC
Investor Relations Contact: Cathy Yudzevich, (518) 514-3091
Web: www.intermagnetics.com
Date of Presentation: 2-28-06 at 11:00 AM EST
Intermagnetics draws on the financial strength, operational
excellence and technical leadership in the market of Magnetic
Resonance Imaging (MRI), as well as its expanding businesses within
Medical Devices that encompass Invivo Diagnostic Imaging (focusing on
MRI components & imaging sub-systems) and Invivo Patient Care
(focusing on monitoring & other patient care devices). Intermagnetics
is also a prominent participant in superconducting applications for
Energy Technology. The company has a 35-year history as a successful
developer, manufacturer and marketer of superconducting materials,
high-field magnets, medical systems & components and other specialized
high-value added devices.
Company: LandAmerica Financial Group, Inc.
Ticker Symbol & Exchange: LFG
Investor Relations Contact: Bob Sullivan, 804-267-8703
Web: www.landam.com
Date of Presentation: March 2nd @ 12:30 p.m.
Based in Richmond, Virginia and listed on the New York Stock
Exchange, LandAmerica is the largest company in the nation dedicated
exclusively to real estate transaction services. Through its principle
underwriters Commonwealth Land Title, Lawyers Title, and Transnation
Title, it has protected the country's real estate investments for 130
years. Today, in addition to title insurance, LandAmerica offers a
complete array of commercial and residential services throughout the
United States and abroad. The company is known for its dedication to
providing customers with consistently Superior Service, which is the
hallmark and guiding force behind the LandAmerica brand.
Company: Matritech
Ticker Symbol & Exchange: MZT (Amex)
Investor Relations Contact: Kathleen O'Donnell, 617-928-0820
Web: www.matritech.com
Date of Presentation: February 27, 2006
Matritech is a leading developer and marketer of protein-based
diagnostic products for the early detection of cancer. The Company's
first two products, the NMP22(R) Test Kit and the NMP22(R)
BladderChek(R) Test, are FDA approved for the monitoring and diagnosis
of bladder cancer. The NMP22(R) BladderChek(R) Test is based on
Matritech's proprietary nuclear matrix protein (NMP) technology, which
correlates levels of NMPs in body fluids to the presence of cancer.
Matritech has discovered other proteins associated with cervical,
breast, prostate, and colon cancer. The Company's goal is to utilize
these protein markers to develop, through its own research staff and
through strategic alliances, clinical applications to detect cancer.
Company: Medivation
Ticker Symbol & Exchange: MDVN.OB (OTC bulletin board)
Investor Relations Contact: Pat Machado, 415.543.3470
Web: www.medivation.com
Date of Presentation: March 1, 2006
Medivation, Inc. seeks to acquire, develop and sell or partner
biomedical technologies in the early-development stage of the research
and development process - the stage beginning with the identification
of a specific biomedical product candidate with a demonstrated
scientific rationale for further development, and ending upon the
completion of Phase II clinical trials designed to provide evidence of
potential safety and efficacy in patients. Medivation currently is
developing Dimebon(TM) for Alzheimer's disease (AD) and Huntington's
disease (HD). Dimebon is a small molecule that has a 20-year record of
human use, has demonstrated improvement in cognition/memory in a pilot
AD clinical trial, and has demonstrated preclinical evidence of
efficacy in animal models of both AD and HD.
Company: Motorcar Parts of America, Inc.
Ticker Symbol & Exchange: MPAA.PK OTC
Investor Relations Contact: Crocker Coulson, 310-477-9800
Web: www.motorcarparts.com
Date of Presentation: 3/2/2006
Motorcar Parts of America, Inc. is a leading remanufacturer of
replacement alternators and starters for imported and domestic cars
and light trucks in the United States and Canada. MPA is one of the
largest suppliers of alternators and starters to the U.S. aftermarket.
In 2004, MPA introduced its Quality Built(TM) line directed at the
professional installer market. MPA has facilities in the United States
in Torrance, California, and Nashville, Tennessee, as well as in
Mexico, Singapore and Malaysia. MPA's websites are located at
www.motorcarparts.com and www.quality-built.com.
Company: MTI
Ticker Symbol & Exchange: MKTY
Investor Relations Contact: George Relan, 518-533-2220
Web: www.mechtech.com
Date of Presentation: March 1st @ 9:40 am
MTI is primarily engaged in the development and commercialization
of award winning Mobion(R) cord-free advanced portable power systems,
through its subsidiary MTI MicroFuel Cells Inc. (MTI Micro). MTI Micro
shipped its first Mobion(R) based product in December 2004, and has a
world-class team of entrepreneurial business executives, researchers
and scientists; a proprietary direct methanol micro fuel cell power
system and a number of system prototypes demonstrating size reductions
and performance improvements; and significant related intellectual
property. MTI Micro has received government awards and developed
strategic partnerships to help accelerate commercialization. MTI is
also engaged in the design, manufacture, and sale of high-performance
test and measurement instruments and systems through its subsidiary
MTI Instruments, Inc.
Company: Nathaniel Energy Corporation
Ticker Symbol & Exchange: OTC BB: NECX
Investor Relations Contact: George Cretecos, 303.690.8300
Web: www.nathanielenergy.com
Date of Presentation: March 1, 2006
Nathaniel Energy Corporation (OTC Bulletin Board: NECX), a
renewable energy leader, announces that it has been invited to present
at the Wall Street Analyst Forums'17th Annual Analyst Conference,
March 1, 2006 at the Princeton Club in New York. Nathaniel will be
presenting on the company, its management, technology, strategy and
preparation for the commercialization of its patented Thermal
Gasifier(TM). We are an "Environmental Partner" that diverts waste
streams from landfills to generate economical clean energy to reduce
the demand on fossil fuels.
Company: Prospect Medical Holdings, Inc.
Ticker Symbol & Exchange: PZZ:AMEX
Investor Relations Contact: Devin Sullivan, 212 836-9608
Web: www.prospectmedical.com
Date of Presentation: 2/28/06
Prospect Medical Holdings manages the medical care of 184,400
individuals enrolled in HMO plans in southern California. Prospect
assumes this responsibility by acquiring Independent Physician
Associations ("IPAs"), which are professional corporations that
contract with health care professionals to provide a full range of
services to HMO enrollees. Prospect does not acquire bricks and
mortar, but rather the medical management of the lives serviced by the
acquired IPAs. Prospect owned 11 IPAs at December 31, 2005, comprised
of approximately 9,000 primary care and specialist physicians. The
Company has contracts with all major regional HMOs and provides a
variety of services, including contract negotiations, HR, physician
recruiting and credentialing, case management, and quality assuance.
Company: Pure Cycle Corporation
Ticker Symbol & Exchange: PCYO - NASDAQ SmallCap
Investor Relations Contact: Kevin McNeill, 303-292-3456
Web: www.purecyclewater.com
Date of Presentation: March 1, 2006
Pure Cycle Corporation provides water and wastewater services to
customers located in the Denver, Colorado metropolitan area. These
services include the design, construction, operation and maintenance
of water and wastewater systems. Our President, Mark Harding, will be
presenting an overview of the Company and providing an update on
recent developments about our valuable assets in the Denver market.
Our common stock is traded on the NASDAQ SmallCap market under the
symbol "PCYO." Additional information is available at our website -
www.purecyclewater.com, or you may contact investor relations at
303-292-3456.
Company: Rowan Companies, Inc.
Ticker Symbol & Exchange: RDC
Investor Relations Contact: W. C. Provine, 713-960-7575
Web: www.rowancompanies.com
Date of Presentation: February 28
Rowan Companies is in its 83rd year as a premium drilling
contractor. Rowan has a fleet of 20 highly capable offshore rigs,
including 7 Gorilla class jack-ups that contract on the deep shelf for
wells between 18,000 - 38,000 feet. Its new generation Tarzan jack-up
class is making a major contribution to the Company. Rowan also
operates 16 high horsepower, high spec land drilling rigs. Under
construction are 4 super-premium jack-ups and eight 2000 horsepower
land rigs. Rowan's manufacturing division, LeTourneau, has built about
one-third of all jack-up rigs, and now builds mud pumps, generators
and top drives used on drilling rigs worldwide.
Company: Synthetic Blood International, Inc.
Ticker Symbol & Exchange: OTC BB: SYBD
Investor Relations Contact: Jody Cain or Brandi Floberg; 310-691-7100
Web: www.sybd.com
Date of Presentation: March 1, 2006 at 9:00 a.m. Eastern Time
Synthetic Blood International, Inc. develops innovative
pharmaceuticals and medical devices with oxygen therapeutic and
continuous substrate monitoring technologies based on perfluorocarbon
(PFC) and biosensor technologies. Each product candidate is designed
with advantages over currently marketed products in major markets,
including acute respiratory distress syndrome, stroke, myocardial
infarction, malignant tumors and diabetes. Synthetic Blood is
currently initiating Phase II proof-of-concept clinical trials with
its proprietary PFC-based oxygen therapeutic Oxycyte(TM) as a safe and
effective therapy for delivering oxygen to systemic tissues in
traumatic brain injury and sickle cell anemia. The Company's other
products include Fluorovent(TM), a liquid ventilator providing oxygen
exchange fluid for facilitating the treatment of lung conditions, and
a biosensor implant product that continuously measures glucose levels
in diabetics. This biosensor technology also has potential industrial
applications for in-process manufacturing control measurements.
Company: Thomas Group, Inc.
Ticker Symbol & Exchange: NasdaqCM:TGIS
Investor Relations Contact: David English, 972-401-4431
Web: www.thomasgroup.com
Date of Presentation: February 27, 2006
Thomas Group, Inc. is an international, publicly traded business
consulting firm (NasdaqCM.TGIS). Thomas Group's unique brand of
process improvement and performance management services enable
businesses to enhance operations, improve productivity and quality,
reduce costs, generate cash and drive higher profitability. Known as
The Results CompanySM, Thomas Group creates and implements customized
improvement strategies for sustained performance improvements in all
facets of the business enterprise. Thomas Group has offices in Dallas,
Detroit, Zug, and Hong Kong. For additional information on Thomas
Group, Inc., please go to www.thomasgroup.com.
Company: Westwood Holdings Group, Inc.
Ticker Symbol & Exchange: NYSE : WHG
Investor Relations Contact: Bill Hardcastle, 214-756-6900
Web: www.westwoodgroup.com
Date of Presentation: March 2, 2006, 9:00am Eastern Time
Westwood Holdings Group, Inc. manages investment assets and
provides services for its clients through two subsidiaries, Westwood
Management Corp. and Westwood Trust. Westwood Management Corp.,
founded in 1983, is a registered investment advisor and provides
investment advisory services to corporate pension funds, public
retirement plans, endowments and foundations, mutual funds and clients
of Westwood Trust. Westwood Trust provides, to institutions and high
net worth individuals, trust and custodial services and participation
in common trust funds that it sponsors. As of December 31, 2005,
Westwood had assets under management of $4.9 billion. Westwood
Holdings Group, Inc. trades on the New York Stock Exchange under the
symbol "WHG." For more information, please visit the Company's website
at www.westwoodgroup.com.
Note to Editors: Business Wire's PressPass allows you to create free, custom Web, RSS and email-based news feeds from more than 160 industry options, dozens of subject categories and thousands of geographic preferences, as well as by specific company filters. In addition, PressPass subscribers have access to exclusive content to experts, company profiles, email alerts, survey services and other media services.
Note to Event Organizers: Add your trade show, conference or event to www.tradeshownews.com, Business Wire's online event calendar. For information, email tradeshow@businesswire.com.